For more VICC news, visit their website »
The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.
A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.
The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States.
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.
More than 650 cancer survivors, family members and cancer health care providers attended Vanderbilt-Ingram Cancer Center’s Cancer Survivorship Celebration earlier this month during a special evening dinner and concert at the Loveless Barn in Nashville.
Accessibility Tools